This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Antiemetic Therapy
and you are
over 18
years old
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

The purpose of this registry is to record information on reality of anti-emetic therapies of cancer-patients in Germany. The outcome of this study is the efficacy of anti-emetic therapies dependent on the rate "complete and major control" of nausea and emesis in moderately and highly emetogenic chemotherapies, consisting of platin-derivates (cisplatin, carboplatin and oxaliplatin), anthracyclines and/or cyclophosphamid.

Provided treatments

  • Other: non-interventional
Tris trial is registered with FDA with number: NCT00911222. The sponsor of the trial is iOMEDICO AG and it is looking for 1035 volunteers for the current phase.
Official trial title:
Epidemiologic Registry for the Description of Antiemetic Strategies Under Real-life Conditions.